DooDiligence Posted April 28, 2017 Posted April 28, 2017 http://catalyst.nejm.org/is-value-based-drug-pricing-compatible-with-pharma-innovation/ The part about enabling payers to migrate the costs of care when the patients themselves move & the burden on payers to manage this risk is interesting...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now